Skip to main content
. 2022 Jan 24;9:822094. doi: 10.3389/fmed.2022.822094

Table 1.

Characteristics of samples.

Pulmonary sarcoidosis
Samples Male/female Age Stage Organ involvements Smoking history
No.1 Female 76 3 Eye, heart None
No.2 Male 56 1 Heart None
No.3 Male 47 3 None None
No.4 Female 68 3 Heart, liver, kidney Yes
No.5 Female 59 2 None Yes
No.6 Female 43 1 None None
No.7 Male 62 1 None Yes
No.8 Female 49 2 None Yes
Healthy controls
Samples Male/female Age Smoking history
No.1 Male 42 None
No.2 Male 31 None
No.3 Female 34 None
No.4 Female 58 None
No.5 Female 45 None
No.6 Female 46 None
No.7 Female 48 None
No.8 Female 43 None
No.9 Male 66 None
No.10 Female 37 None
No.11 Female 40 None
Pulmonary sarcoidosis vs. healthy controls
Pulmonary sarcoidosis Healthy controls P -value
Age 58.1 ± 11.5 44.5 ± 10.2 0.01*
Gender (male/female) 3/5 3/8 1.0#
*

Student's t-test.

#

Fisher's exact test.